{"id":565774,"date":"2017-11-30T21:05:00","date_gmt":"2017-11-30T21:05:00","guid":{"rendered":"https:\/\/www.pm360online.com\/?guid=c53d31c7784253d06a414d5ef5f4aadb"},"modified":"2017-11-30T21:05:00","modified_gmt":"2017-11-30T21:05:00","slug":"horizon-pharma-plc-to-participate-in-bmo-prescriptions-for-success-healthcare-conference-3","status":"publish","type":"post","link":"https:\/\/www.pm360online.com\/horizon-pharma-plc-to-participate-in-bmo-prescriptions-for-success-healthcare-conference-3\/","title":{"rendered":"Horizon Pharma plc to Participate in BMO Prescriptions for Success Healthcare Conference"},"content":{"rendered":"<p align=\"left\">DUBLIN, Ireland, Nov.  30, 2017  (GLOBE NEWSWIRE) &#8212; Horizon Pharma plc (Nasdaq:<a href=\"http:\/\/globenewswire.com\/News\/Listing?symbol=HZNP&#038;exchange=2\">HZNP<\/a>), a biopharmaceutical company focused on improving patients&#8217; lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will participate in the following conference in December:<\/p>\n<p><strong><em>BMO Prescriptions for Success Healthcare Conference<\/em><\/strong><\/p>\n<ul type=\"disc\">\n<li>Date: \u00a0Dec. 14, 2017<\/li>\n<li>Presentation Time: \u00a02:30 p.m. ET<\/li>\n<li>Location: \u00a0New York, NY<\/li>\n<\/ul>\n<p>The presentation will be webcast live and may be accessed by visiting Horizon&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vLcYnFKJYbhdJEbrcBNjA8qVDFRbTB0nAFp0mvVHDoXyWk9vHgagrYm8AVV-SNMtFZNTxQiacuCBWdMUZB2UszXqEhtGe1hAads8rFTNtepIkvI03JXXnYkIcdi7l-Bual4B5Ynn-dLMZV5CkqMeBZCb9XscFhbwJRDzi2QmRn8mzEoU7E_aH0Y6Qa0FFZUcszPV8UesBxudr0sz4bkQFQ==\" rel=\"nofollow\"  title=\"\">http:\/\/ir.horizon-pharma.com<\/a>. \u00a0A replay of the webcast will be available for the event.<\/p>\n<p><strong><em>About Horizon Pharma plc<br \/> <\/em><\/strong>Horizon Pharma plc is a biopharmaceutical company focused on improving patients&#8217; lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs.\u00a0 The Company markets 11 medicines through its orphan, rheumatology and primary care business units.\u00a0 For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YlDuUgqGHO4rAFiCn3hDvolazu72LukIrSFqGbkf1WzOudAjKD9wSgxVeWj8mmUQ7kNCE6ES8tbLHs4BiYZGD1UedBWUT6AWLwU5F3qXtNyJCyQFzSicGjoDMj-_VoFDNjPXXYGj54hFjcduEgteq8I66yOVJ9rf_IZ-b-ppLMfw4TsTNtLe3-PAr3yClrL8QvRsqW2Ex-lde7SRkFp5dQ==\" rel=\"nofollow\"  title=\"www.horizonpharma.com\">www.horizonpharma.com<\/a>.\u00a0 Follow <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zXTg72Lfqt1qH-0rzC3u3_9dFOQiDVddR474IoBFYHf5iOLF18u9ETOJ8dPkibFWKuAI_DdWl4OSgMnI3tZbOsZwXTSOooZJBdK_EGCtZiKyW9yRCSSt4bVqji7H1_1uIR_sNX__QuwQJ2xOKnVrGtZEl8zjP3WKQ6bw9CfemxqXcYiZW6oHCz33JjS6Yeok\" rel=\"nofollow\"  title=\"@HZNPplc\">@HZNPplc<\/a> on Twitter or view careers on our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-9vTMJXDm905i9meKWguEnw1WE55of55kVAuaSLTJBvPaW3BgVVn0wFTM2fbVF-LvGflYNViKG8SmicUzwv50jq_WSdDb8lBbRxcV8BL_z53mHTZpBkhvgy4EQiGsjR_ApRTOQIqUDEIYFqTqOBZJo7eQrM_MPnAbCW3ziyiPoWonPes3ns_KpHQ5E7p2cYrw1exccykGVBKc76gwLhrQA==\" rel=\"nofollow\"  title=\"LinkedIn\">LinkedIn<\/a> page.<\/p>\n<p><strong>Contacts:<\/strong><\/p>\n<p><strong>Investors:\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/strong><br \/>Tina Ventura\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<br \/>Senior Vice President,<br \/>Investor Relations\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Dn-jGlpeIKN_V9rmtatKsetTpPv2nGUMMjDNzN_T--dT9oz0JG9XTzgT6_XYC_o_CeRhKCexMl-VCe7VwhHK68sYpEujpEnN0jK7-uXWT5IAfxq_Iw1q51fmgTpW8xOCW1G7nPBKKtCThMcg0kRB_Q==\" rel=\"nofollow\"  title=\"investor-relations@horizonpharma.com\">investor-relations@horizonpharma.com<\/a>\u00a0<\/p>\n<p>Ruth Venning\u00a0 \u00a0<br \/>Executive Director,\u00a0\u00a0<br \/>Investor Relations\u00a0 \u00a0 \u00a0 \u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Dn-jGlpeIKN_V9rmtatKsetTpPv2nGUMMjDNzN_T--djQJ4JqL2EDxjJ5dY7A_bA40O3s6TQhmQI__6rz4gRng-qMlb6e9y15u_07EtZLYktvRTNKFonvWi6OAp-sNEG2qCWB4OMOgWmaGyI3Eif1A==\" rel=\"nofollow\"  title=\"investor-relations@horizonpharma.com\">investor-relations@horizonpharma.com<\/a>\u00a0\u00a0<\/p>\n<p><strong>U.S. Media:<br \/><\/strong>Geoff Curtis<br \/>Senior Vice President,<br \/>Corporate Affairs &amp; Chief Communications Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6eb2wEwWZKqRtngBhGZwac4EDqsmTs61f-_qYVnC_4CDhSqpzbFaLzTXG9EsLpyFwK4YvZufIsxLx0PItV7Bbh7_17bEa3UL_2Qod56QWm8=\" rel=\"nofollow\"  title=\"media@horizonpharma.com\">media@horizonpharma.com<\/a><strong><br \/><\/strong><\/p>\n<p><strong>Ireland Media:<\/strong><br \/>Ray Gordon<br \/>Gordon MRM<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MwxN9CH1v2mACkdp0LIbKuYOCcv4LuMZhaSlydeNHfDH0V883s0eQ20cR1GLSN9A9pXXZ0uI-jKPXk0n_d6PSQ==\" rel=\"nofollow\"  title=\"ray@gordonmrm.ie\">ray@gordonmrm.ie<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p class=\"small\" align=\"left\">DUBLIN, Ireland, Nov.  30, 2017  (GLOBE NEWSWIRE) &#8212; Horizon Pharma plc (Nasdaq:<a href=\"http:\/\/globenewswire.com\/News\/Listing?symbol=HZNP&amp;exchange=2\">HZNP<\/a>), a biopharmaceutical company focused on improving patients&#8217; lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will participate in the following conference in December:<\/p>\n<p class=\"small\"><strong><em>BMO Prescriptions for Success Healthcare Conference<\/em><\/strong><\/p>\n<ul type=\"disc\">\n<li>Date: &nbsp;Dec. 14, 2017<\/li>\n<li>Presentation Time: &nbsp;2:30 p.m. ET<\/li>\n<li>Location: &nbsp;New York, NY<\/li>\n<\/ul>\n<p class=\"small\">The presentation will be webcast live and may be accessed by visiting Horizon&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vLcYnFKJYbhdJEbrcBNjA8qVDFRbTB0nAFp0mvVHDoXyWk9vHgagrYm8AVV-SNMtFZNTxQiacuCBWdMUZB2UszXqEhtGe1hAads8rFTNtepIkvI03JXXnYkIcdi7l-Bual4B5Ynn-dLMZV5CkqMeBZCb9XscFhbwJRDzi2QmRn8mzEoU7E_aH0Y6Qa0FFZUcszPV8UesBxudr0sz4bkQFQ==\" rel=\"nofollow\" target=\"_blank\" title=\"\">http:\/\/ir.horizon-pharma.com<\/a>. &nbsp;A replay of the webcast will be available for the event.<\/p>\n<p class=\"small\"><strong><em>About Horizon Pharma plc<br \/><\/em><\/strong>Horizon Pharma plc is a biopharmaceutical company focused on improving patients&#8217; lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs.&nbsp; The Company markets 11 medicines through its orphan, rheumatology and primary care business units.&nbsp; For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YlDuUgqGHO4rAFiCn3hDvolazu72LukIrSFqGbkf1WzOudAjKD9wSgxVeWj8mmUQ7kNCE6ES8tbLHs4BiYZGD1UedBWUT6AWLwU5F3qXtNyJCyQFzSicGjoDMj-_VoFDNjPXXYGj54hFjcduEgteq8I66yOVJ9rf_IZ-b-ppLMfw4TsTNtLe3-PAr3yClrL8QvRsqW2Ex-lde7SRkFp5dQ==\" rel=\"nofollow\" target=\"_blank\" title=\"www.horizonpharma.com\">www.horizonpharma.com<\/a>.&nbsp; Follow <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zXTg72Lfqt1qH-0rzC3u3_9dFOQiDVddR474IoBFYHf5iOLF18u9ETOJ8dPkibFWKuAI_DdWl4OSgMnI3tZbOsZwXTSOooZJBdK_EGCtZiKyW9yRCSSt4bVqji7H1_1uIR_sNX__QuwQJ2xOKnVrGtZEl8zjP3WKQ6bw9CfemxqXcYiZW6oHCz33JjS6Yeok\" rel=\"nofollow\" target=\"_blank\" title=\"@HZNPplc\">@HZNPplc<\/a> on Twitter or view careers on our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-9vTMJXDm905i9meKWguEnw1WE55of55kVAuaSLTJBvPaW3BgVVn0wFTM2fbVF-LvGflYNViKG8SmicUzwv50jq_WSdDb8lBbRxcV8BL_z53mHTZpBkhvgy4EQiGsjR_ApRTOQIqUDEIYFqTqOBZJo7eQrM_MPnAbCW3ziyiPoWonPes3ns_KpHQ5E7p2cYrw1exccykGVBKc76gwLhrQA==\" rel=\"nofollow\" target=\"_blank\" title=\"LinkedIn\">LinkedIn<\/a> page.<\/p>\n<p class=\"small\"><strong>Contacts:<\/strong><\/p>\n<p class=\"small\"><strong>Investors:&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<\/strong><br \/>Tina Ventura&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;<br \/>Senior Vice President,<br \/>Investor Relations&nbsp;<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Dn-jGlpeIKN_V9rmtatKsetTpPv2nGUMMjDNzN_T--dT9oz0JG9XTzgT6_XYC_o_CeRhKCexMl-VCe7VwhHK68sYpEujpEnN0jK7-uXWT5IAfxq_Iw1q51fmgTpW8xOCW1G7nPBKKtCThMcg0kRB_Q==\" rel=\"nofollow\" target=\"_blank\" title=\"investor-relations@horizonpharma.com\">investor-relations@horizonpharma.com<\/a>&nbsp;<\/p>\n<p class=\"small\">Ruth Venning&nbsp; &nbsp;<br \/>Executive Director,&nbsp;&nbsp;<br \/>Investor Relations&nbsp; &nbsp; &nbsp; &nbsp;<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Dn-jGlpeIKN_V9rmtatKsetTpPv2nGUMMjDNzN_T--djQJ4JqL2EDxjJ5dY7A_bA40O3s6TQhmQI__6rz4gRng-qMlb6e9y15u_07EtZLYktvRTNKFonvWi6OAp-sNEG2qCWB4OMOgWmaGyI3Eif1A==\" rel=\"nofollow\" target=\"_blank\" title=\"investor-relations@horizonpharma.com\">investor-relations@horizonpharma.com<\/a>&nbsp;&nbsp;<\/p>\n<p class=\"small\"><strong>U.S. Media:<br \/><\/strong>Geoff Curtis<br \/>Senior Vice President,<br \/>Corporate Affairs &amp; Chief Communications Officer<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6eb2wEwWZKqRtngBhGZwac4EDqsmTs61f-_qYVnC_4CDhSqpzbFaLzTXG9EsLpyFwK4YvZufIsxLx0PItV7Bbh7_17bEa3UL_2Qod56QWm8=\" rel=\"nofollow\" target=\"_blank\" title=\"media@horizonpharma.com\">media@horizonpharma.com<\/a><strong><br \/><\/strong><\/p>\n<p class=\"small\"><strong>Ireland Media:<\/strong><br \/>Ray Gordon<br \/>Gordon MRM<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MwxN9CH1v2mACkdp0LIbKuYOCcv4LuMZhaSlydeNHfDH0V883s0eQ20cR1GLSN9A9pXXZ0uI-jKPXk0n_d6PSQ==\" rel=\"nofollow\" target=\"_blank\" title=\"ray@gordonmrm.ie\">ray@gordonmrm.ie<\/a><\/p>\n","protected":false},"author":74553,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[71350,71364],"tags":[],"_links":{"self":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts\/565774"}],"collection":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/users\/74553"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/comments?post=565774"}],"version-history":[{"count":0,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/posts\/565774\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/media?parent=565774"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/categories?post=565774"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pm360online.com\/wp-json\/wp\/v2\/tags?post=565774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}